How many employees does AIM have?

AIM has approximately 86 employees.

Where is AIM headquartered?

While a specific address is not provided, the company is an MIT spinout, suggesting an initial base in Cambridge, Massachusetts.

Yes, AIM was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.

How do I sell to AIM?

Research AIM's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details.

Data Surfer

How it works Insights Pricing FAQ Contact Login

AIM

Biotechnology

Cambridge, USA

86 employees

Founded 2015

aim.vision

Verified active February 2, 2026

Key Highlights

AIM Biotech is an MIT spinout company focused on advanced cell culture technology.
They have developed a unique microfluidics device for 3-D hydrogel cell co-culturing.
Their technology accurately mimics natural tissue environments for biological research.
AIM Biotech's platform is used to study complex processes like cancer metastasis.
Researchers utilize their device to test cancer cell reactions to chemotherapy agents.

About AIM

AIM Biotech is an MIT spinout that has developed a microfluidics device enabling researchers to co-culture multiple cell types in a 3-D hydrogel environment. This technology mimics natural tissue to accurately study biological processes, such as cancer metastasis, and the reaction of cancer cells to chemotherapy agents.

Company Facts

Ownership Private Company

Technology Stack

microfluidics
3-D hydrogel environment

Why Contact AIM?

AIM Biotech develops microfluidics devices that allow researchers to co-culture multiple cell types in a 3-D hydrogel environment to mimic natural tissue for studying biological processes like cancer

Who Should Contact AIM for Business?

The company develops and likely sells microfluidics devices for biological research and drug testing.

More Biotechnology Companies

National Science And Technology Development Agency Nstda

View all Biotechnology companies

Frequently Asked Questions

What does AIM do?: AIM Biotech develops microfluidics devices that allow researchers to co-culture multiple cell types in a 3-D hydrogel environment to mimic natural tissue for studying biological processes like cancer metastasis.
How many employees does AIM have?: AIM has approximately 86 employees.
Where is AIM headquartered?: While a specific address is not provided, the company is an MIT spinout, suggesting an initial base in Cambridge, Massachusetts.
What industry is AIM in?: AIM operates in Biotechnology.
When was AIM founded?: AIM was founded in 2015.
Is AIM still active?: Yes, AIM was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to AIM?: Research AIM's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.